Aptorum Group Limited (NASDAQ:APM) Sees Significant Drop in Short Interest

Aptorum Group Limited (NASDAQ:APM) was the recipient of a significant decrease in short interest during the month of March. As of March 31st, there was short interest totalling 23,600 shares, a decrease of 46.2% from the March 15th total of 43,900 shares. Based on an average daily trading volume, of 124,300 shares, the days-to-cover ratio is currently 0.2 days. Currently, 0.5% of the company’s stock are sold short.

Aptorum Group Stock Performance

Shares of APM stock opened at $0.98 on Wednesday. The firm has a fifty day moving average of $0.97 and a 200-day moving average of $1.15. Aptorum Group has a 52-week low of $0.46 and a 52-week high of $7.88.

Aptorum Group Company Profile

Aptorum Group Limited, a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products for the treatment of infectious diseases and cancer. The company operates in the Therapeutics and Non-Therapeutics segments. Its pipeline products include SACT- 1 for neuroblastoma and other cancer types; SACT-COV19 for the treatment of coronavirus disease; ALS-4 to treat bacterial infections caused by staphylococcus aureus, including MRSA; and ALS-1 to treat viral infections caused by influenza virus A.